Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Latest Attention Deficit Hyperactivity Disorder (ADHD) News and Research

New autism research findings presented at 10th annual IMFAR

Much about autism is unknown, but researchers from the University of Rochester Medical Center (URMC) are working to learn more about the neurodevelopmental disorder and its most effective treatments. A team of researchers from URMC joins researchers from across the world in San Diego this week for the 10th annual International Meeting for Autism Research (IMFAR).

16 May 2011

VAYA Pharma's Vayarin now available in South, North Carolina and Texas for children with ADHD

\VAYA Pharma announced the availability of Vayarin in pharmacies throughout North Carolina, South Carolina and Texas for children suffering with Attention-Deficit / Hyperactivity Disorder (ADHD).

16 May 2011

Otsuka Pharmaceutical reports OPC-34712 Phase 2 trial results in major depressive disorder

Otsuka Pharmaceutical Co., Ltd. (OPC) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) today announced results from a Phase 2 clinical trial of OPC-34712, a novel D2 dopamine partial agonist investigational product.

16 May 2011

Longer looks: Conservatives vs. liberals on Medicare - who's winning?

What you really need to know is that Tuesday was a great day in court for supporters of the Care Act and a very tough one for its opponents. That dynamic could easily change within the next six weeks or so when the 11th Circuit, the 6th Circuit, and the 3rd Circuit also hold their oral arguments on Care Act appeals. Either way, we are one step closer to the end of all of this, and you can bet that the justices were paying attention up the road a bit from Richmond.

13 May 2011

ADHD in children linked to stress and depression during pregnancy

According to the latest research women who are depressed or severely stressed during their pregnancy have a greater chance of having children with attention deficit hyperactivity disorder. It has been known till now that ADHD is largely inheritable but now it comes out that antenatal anxiety could contribute to 15 per cent of cases of the behavioural condition in children.

8 May 2011

Alza files patent infringement suit against Impax in connection with Concerta

Impax Laboratories, Inc. today confirms that Alza Corporation has filed suit for patent infringement against Impax in the United States District Court for the District of Delaware in connection with Concerta extended-release 18, 27 and 36 mg tablets.

7 May 2011

Study explores impact of environmental toxins on health care costs and childhood morbidity

In three new studies published in the May issue of the journal Health Affairs, Mount Sinai School of Medicine researchers reveal the staggering economic impact of toxic chemicals and air pollutants in the environment, and propose new legislation to mandate testing of new chemicals and also those already on the market.

5 May 2011

Marianjoy Medical Library launches new website on developmental problems, chronic conditions

InformationConnections.org, the informative website for parents of children with developmental disabilities and chronic diseases, was recently launched by the Marianjoy Medical Library. The National Network of Libraries of Medicine, Greater Midwest Region, provided a grant to create and manage the website.

5 May 2011

Watson introduces generic version of Concerta

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., has launched an authorized generic version of Concerta as part of an exclusive agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc.

2 May 2011

Brain function variations may increase person's risk of drug abuse

One can look at drug addiction as a moral issue, a social ill, or a criminal problem. But Lynn Oswald's experience studying the neuroscience of addiction tells her that it is something else entirely: a disease of the brain.

30 Apr 2011

Positive results from Shire's Vyvanse clinical trial in schizophrenia

Shire plc, the global specialty biopharmaceutical company, today announced positive results from a signal-finding study of Vyvanse(R) Capsules assessing its effect in a prospective examination of adults with negative symptom predominant schizophrenia.

28 Apr 2011

USPTO grants Cortex patent for CX1739 AMPAKINE molecule

Cortex Pharmaceuticals, Inc. announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a patent that protects its lead AMPAKINE® molecule, CX1739.

26 Apr 2011

KemPharm to formulate and develop KP106 as oral film dosage for ADHD treatment

KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.

26 Apr 2011

MonoSol Rx, KemPharm enter development and commercialization partnership for ADHD prodrug

MonoSol Rx, LLC, the developer of PharmFilm® drug delivery technology, today announced that the Company has entered into a development and commercialization partnership with KemPharm, a biopharmaceutical company focused on the discovery and development of new, safer therapies for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), pain, and cardiovascular disease.

25 Apr 2011

Mindfulness meditation may enhance mental abilities

The positive effects of mindfulness meditation on pain and working memory may result from an improved ability to regulate a crucial brain wave called the alpha rhythm.

22 Apr 2011

Parks and green environments impact social, psychological and physical health outcomes

Research shows that a walk in the park is more than just a nice way to spend an afternoon. It's an essential component for good health, according to University of Illinois environment and behavior researcher Frances "Ming" Kuo.

20 Apr 2011

Swinburne University of Technology acquires Elekta's Neuromag TRIUX MEG system

Certain brain processes happen in the blink of an eye – and even faster – which has made pinpointing these events virtually impossible. The advent of magnetoencephalography (MEG) changed all that, enabling researchers to capture brain electrical activity measured in milliseconds, and offering the potential to reveal the nature of innumerable brain disorders and diseases.

From Elekta 20 Apr 2011

Scientists identify filter neurons that can reduce 'brain clutter'

Until now, it has been assumed that people with diseases like ADHD, Tourette syndrome, obsessive compulsive disorder and schizophrenia - all of whom characteristically report symptoms of "brain clutter" - may suffer from anomalies in the brain's prefrontal cortex.

15 Apr 2011

Scientists identify gene influencing levels of alcohol consumption

Scientists have identified a gene that appears to play a role in regulating how much alcohol people drink, in a study of over 47,000 people published today in Proceedings of the National Academy of Sciences.

5 Apr 2011

National Alliance for Research on Schizophrenia and Depression is now Brain & Behavior Research Foundation

The Brain & Behavior Research Foundation (formerly NARSAD, the National Alliance for Research on Schizophrenia and Depression) continues its 25-year mission to alleviate the suffering of mental illness by awarding grants that will lead to advances and breakthroughs in scientific research.

5 Apr 2011

Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Latest Attention Deficit Hyperactivity Disorder (ADHD) News and Research

New autism research findings presented at 10th annual IMFAR

VAYA Pharma's Vayarin now available in South, North Carolina and Texas for children with ADHD

Otsuka Pharmaceutical reports OPC-34712 Phase 2 trial results in major depressive disorder

Longer looks: Conservatives vs. liberals on Medicare - who's winning?

ADHD in children linked to stress and depression during pregnancy

Alza files patent infringement suit against Impax in connection with Concerta

Study explores impact of environmental toxins on health care costs and childhood morbidity

Marianjoy Medical Library launches new website on developmental problems, chronic conditions

Watson introduces generic version of Concerta

Brain function variations may increase person's risk of drug abuse

Positive results from Shire's Vyvanse clinical trial in schizophrenia

USPTO grants Cortex patent for CX1739 AMPAKINE molecule

KemPharm to formulate and develop KP106 as oral film dosage for ADHD treatment

MonoSol Rx, KemPharm enter development and commercialization partnership for ADHD prodrug

Mindfulness meditation may enhance mental abilities

Parks and green environments impact social, psychological and physical health outcomes

Swinburne University of Technology acquires Elekta's Neuromag TRIUX MEG system

Scientists identify filter neurons that can reduce 'brain clutter'

Scientists identify gene influencing levels of alcohol consumption

National Alliance for Research on Schizophrenia and Depression is now Brain & Behavior Research Foundation

Industry Focus eBook - Pharmaceutical Manufacturing (1st edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Latest Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Industry Focus eBook - Pharmaceutical Manufacturing (1st edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in